Insider Trading Activity - ARCH Venture Fund XII, L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for ARCH Venture Fund XII, L.P.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2025-02-03 Purchase	2025-02-03 7:01 pm	Metsera Inc.	MTSR	ARCH Venture Partners XII LLC ARCH Venture Fund XII L.P. ARCH Venture Partners XII L.P. ARCH Venture Fund XIII L.P. ARCH Venture Partners XIII L.P. ARCH Venture Partners XIII LLC CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	2,222,222	$18	$39,999,996	8,313,680 (Indirect)	View
2024-02-15 Purchase	2024-02-20 5:38 pm	Prime Medicine Inc.	PRME	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. 10% Owner	3,200,000	$6.25	$20,000,000	15,456,594 (Indirect)	View
2023-11-13 Purchase	2023-11-15 6:54 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	35,010	$11.77	$412,140	4,131,207 (Indirect)	View
2023-11-08 Purchase	2023-11-13 7:00 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	140,605	$10.98	$1,543,563	4,096,197 (Indirect)	View
2023-11-03 Purchase	2023-11-07 6:59 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	95,694	$11.49	$1,099,945	3,955,592 (Indirect)	View
2023-09-28 Purchase	2023-09-29 6:53 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	76,511	$13.68	$1,046,848	3,859,898 (Indirect)	View
2023-09-26 Purchase	2023-09-27 8:18 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	58,504	$11.97	$700,464	3,783,387 (Indirect)	View
2023-09-22 Purchase	2023-09-25 9:38 pm	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	100,740	$11.19	$1,127,064	3,724,883 (Indirect)	View
2023-09-19 Purchase	2023-09-20 06:16 am	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	1,500,000	$17	$25,500,000	3,624,143 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2025-02-03 Conversion	2025-02-03 7:01 pm	N/A N/A	Metsera Inc.	MTSR	ARCH Venture Partners XII LLC ARCH Venture Fund XII L.P. ARCH Venture Partners XII L.P. ARCH Venture Fund XIII L.P. ARCH Venture Partners XIII L.P. ARCH Venture Partners XIII LLC CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	78,821,106	$0	8,313,680 (Indirect)	View
Ownership	2025-01-30 9:25 pm	N/A N/A	Metsera Inc.	MTSR	ARCH Venture Partners XII LLC ARCH Venture Fund XII L.P. ARCH Venture Partners XII L.P. ARCH Venture Fund XIII L.P. ARCH Venture Partners XIII L.P. ARCH Venture Partners XIII LLC CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT 10% Owner	0	$0	24,594,586 (Indirect)	View
2024-06-10 Conversion	2024-06-10 7:46 pm	N/A N/A	Rapport Therapeutics Inc.	RAPP	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner	35,652,876	$0	3,728,738 (Indirect)	View
Ownership	2024-06-06 7:14 pm	N/A N/A	Rapport Therapeutics Inc.	RAPP	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner	0	$0	3,728,738 (Indirect)	View
2023-12-08 Other	2023-12-12 7:53 pm	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	1,879,654	$0	32,424,564 (Indirect)	View
2023-09-19 Conversion	2023-09-20 06:16 am	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	17,424,704	$0	3,624,143 (Indirect)	View
Ownership	2023-09-14 9:29 pm	N/A N/A	Neumora Therapeutics Inc.	NMRA	ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner	0	$0	28,045,420 (Indirect)	View

Insider Trading & Ownership - ARCH Venture Fund XII, L.P.